TP53 and neoplasm: Paired tumor-normal targeted sequencing in six cases, including a gHRD case with a BRCA1 inactivating mutation, revealed highly recurrent TP53 somatic mutations in IBC-MGA, akin to both MGA and those reported in conventional TNBC and mammary acinic cell carcinoma (AciCC)12–13.